Skip to content

Drug interactions

Ibrutinib + Ribociclib

Severity: Major

Ibrutinib and Ribociclib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ribociclib inhibits CYP3A4 and ibrutinib is extensively metabolized by this enzyme, so ibrutinib exposure rises. This increases risks of bleeding, arrhythmia, cytopenias and other toxicities.

What this interaction means in plain words

Ibrutinib and Ribociclib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ibrutinib belongs to Oncology; Ribociclib belongs to Oncology.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated first-pass and hepatic metabolism of ibrutinib.

What to do

Reduce the ibrutinib dose as per labeling for moderate CYP3A inhibitors and monitor for toxicity, including bleeding and arrhythmia. Resume the usual dose after ribociclib is stopped.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ibrutinib and Ribociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ibrutinib with Ribociclib?

MediHelp rates the interaction as major. Ibrutinib and Ribociclib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ribociclib inhibits CYP3A4 and ibrutinib is extensively metabolized by this enzyme, so ibrutinib exposure rises. This increases risks of bleeding, arrhythmia, cytopenias and other toxicities.

How serious is the interaction between Ibrutinib and Ribociclib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce the ibrutinib dose as per labeling for moderate CYP3A inhibitors and monitor for toxicity, including bleeding and arrhythmia. Resume the usual dose after ribociclib is stopped.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in